{"id":"https://openalex.org/W2625237238","doi":null,"title":"\"Multiplex\" targeting of metastatic cells: The IRS-2 paradigm.","display_name":"\"Multiplex\" targeting of metastatic cells: The IRS-2 paradigm.","publication_year":2007,"publication_date":"2007-11-15","ids":{"openalex":"https://openalex.org/W2625237238","mag":"2625237238"},"language":"en","primary_location":{"id":"mag:2625237238","doi":null,"is_oa":false,"landing_page_url":"https://clincancerres.aacrjournals.org/content/13/22_Supplement/B19","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049543815","display_name":"Anja Huq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163471","display_name":"Protigen (United States)","ror":"https://ror.org/018b8fj92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163471"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anja Huq","raw_affiliation_strings":["Protigen, Inc., Sunnyvale, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protigen, Inc., Sunnyvale, CA","institution_ids":["https://openalex.org/I4210163471"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075918440","display_name":"Desmond D. Mascarenhas","orcid":"https://orcid.org/0000-0002-0710-9960","observed_orcids":["https://orcid.org/0000-0002-0710-9960"]},"institutions":[{"id":"https://openalex.org/I4210163471","display_name":"Protigen (United States)","ror":"https://ror.org/018b8fj92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163471"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Desmond Mascarenhas","raw_affiliation_strings":["Protigen, Inc., Sunnyvale, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protigen, Inc., Sunnyvale, CA","institution_ids":["https://openalex.org/I4210163471"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210163471"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.29319062,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.2761000096797943,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.2761000096797943,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.10589999705553055,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.10119999945163727,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.7099999785423279},{"id":"https://openalex.org/keywords/irs2","display_name":"insulin receptor substrate 2","score":0.8349999785423279},{"id":"https://openalex.org/keywords/irs-1","display_name":"IRS-1","score":0.5830000042915344},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.7260000109672546},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.9129999876022339},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.996999979019165},{"id":"https://openalex.org/keywords/mda-mb-231-breast-cancer","display_name":"MDA-MB-231 breast cancer","score":0.8059999942779541},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/bone-marrow-targeting","display_name":"bone marrow targeting","score":0.878000020980835},{"id":"https://openalex.org/keywords/mdm2","display_name":"MDM2","score":0.7269999980926514},{"id":"https://openalex.org/keywords/protein-kinase-c","display_name":"protein kinase C","score":0.6019999980926514},{"id":"https://openalex.org/keywords/scfv-antibodies","display_name":"scFv antibodies","score":0.6299999952316284},{"id":"https://openalex.org/keywords/tumor-selectivity","display_name":"tumor selectivity","score":0.574999988079071},{"id":"https://openalex.org/keywords/disseminated-cancer","display_name":"disseminated cancer","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6432831287384033},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6379462480545044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5668193101882935},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5332427024841309},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.47310924530029297},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4639095664024353},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.440609335899353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41678088903427124},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4141005873680115},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3937007188796997},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.348858505487442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17959490418434143},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2625237238","doi":null,"is_oa":false,"landing_page_url":"https://clincancerres.aacrjournals.org/content/13/22_Supplement/B19","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2328665307","https://openalex.org/W2497772007","https://openalex.org/W2911002810","https://openalex.org/W1991154919","https://openalex.org/W2108072032","https://openalex.org/W7082658335","https://openalex.org/W2138152358","https://openalex.org/W1534252274","https://openalex.org/W2010089138","https://openalex.org/W7096202928"],"abstract_inverted_index":{"B19":[0],"Disseminated":[2],"metastatic":[3,15,98],"disease":[4,135],"is":[5,22],"the":[6,18,82,108,188],"primary":[7],"cause":[8],"of":[9,44,95,112,126,133,141],"cancer":[10,102,143,180],"deaths.":[11],"What":[12],"differentiates":[13],"a":[14],"variant":[16],"from":[17,187],"original":[19],"tumor":[20],"community":[21],"not":[23],"well":[24],"understood,":[25],"but":[26],"may":[27,47],"involve":[28],"an":[29,61,92,159,165],"improved":[30],"phenotypic":[31],"ability":[32],"to":[33,35,60,75,114,179,183],"adapt":[34],"new":[36],"environments":[37],"and":[38,53,103,117,122,144,154],"cope":[39],"with":[40],"stress.":[41],"Biochemical":[42],"correlates":[43],"such":[45],"phenotypes":[46],"include":[48],"deregulated":[49],"IRS-2/Akt":[50],"signalling,":[51],"NF-kappa-B":[52],"p38":[54],"MAPK":[55],"stress":[56],"kinase,":[57],"all":[58],"secondary":[59],"underlying":[62],"genetic":[63],"propensity":[64],"for":[65,100],"change.":[66],"We":[67,105],"show":[68,176],"that":[69,72],"MDA-MB-231":[70],"cells":[71,125,186],"successfully":[73],"metastasize":[74],"liver":[76],"have":[77,106],"higher":[78],"IRS2:IRS1":[79],"ratios":[80],"than":[81],"parental":[83],"cell":[84],"population.":[85],"Bone":[86],"marrow":[87,128],"has":[88],"been":[89],"suggested":[90],"as":[91],"important":[93],"point":[94],"intervention":[96],"in":[97,129,138],"process":[99],"breast":[101,142],"leukemia.":[104],"used":[107],"metal-binding":[109],"domain":[110],"(MBD)":[111],"IGFBP-3":[113],"target":[115],"small":[116],"large":[118],"protein":[119],"molecules":[120],"directly":[121],"efficiently":[123],"into":[124],"bone":[127],"vivo.":[130],"Effective":[131],"reduction":[132],"disseminated":[134],"was":[136],"achieved":[137],"mouse":[139],"models":[140],"leukemia":[145],"when":[146],"multiple":[147],"inhibitor":[148],"sequences":[149],"targeting":[150],"NF-kappa-B,":[151],"MDM-2,":[152],"P38MAPK,":[153],"PKC":[155],"were":[156],"combined":[157],"on":[158,164],"MBD":[160],"peptide":[161],"scaffold":[162],"or":[163],"MBD-scFV":[166],"antibody":[167],"scaffold.":[168],"In":[169],"vitro,":[170],"these":[171],"same":[172,189],"multiplex":[173],"drug":[174],"candidates":[175],"exquisite":[177],"selectivity":[178],"(when":[181],"compared":[182],"matched":[184],"non-cancer":[185],"patient).":[190]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-06-23T00:00:00"}